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ABSTRACT 31 
Coxiella burnetii and members of the genus Rickettsia are obligate intracellular bacteria. 32 
Since cultivation of these organisms requires dedicated techniques, their diagnosis usually 33 
relies on serological or molecular biology methods. Immunofluorescence is considered the 34 
gold standard to detect antibody-reactivity towards these organisms. Here, we assessed the 35 
performance of a new automated epifluorescence immunoassay (InoDiag) to detect IgM and 36 
IgG against C. burnetii, Rickettsia typhi and Rickettsia conorii. 37 
Samples were tested with the InoDiag assay. A total of 213 sera were tested, of which 63 38 
samples from Q fever, 20 from spotted fever rickettsiosis, 6 from murine typhus and 124 39 
controls. InoDiag results were compared to micro-immunofluorescence. 40 
For acute Q fever, the sensitivity of phase 2 IgG was only of 30% with a cutoff of 1 arbitrary 41 
unit (AU). In patients with acute Q fever with positive IF IgM, sensitivity reached 83% with 42 
the same cutoff. Sensitivity for chronic Q fever was 100% whereas sensitivity for past Q fever 43 
was 65%. Sensitivity for spotted Mediterranean fever and murine typhus were 91% and 44 
100%, respectively. Both assays exhibited a good specificity in control groups, ranging from 45 
79% in sera from patients with unrelated diseases or EBV positivity to 100% in sera from 46 
healthy patients. 47 
In conclusion, the InoDiag assay exhibits an excellent performance for the diagnosis of 48 
chronic Q fever but a very low IgG sensitivity for acute Q fever likely due to low reactivity of 49 
phase 2 antigens present on the glass slide. This defect is partially compensated by the 50 
detection of IgM. Because it exhibits a good negative predictive value, the InoDiag assay is 51 
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valuable to rule out a chronic Q fever. For the diagnosis of Rickettsial diseases, the sensitivity 52 
of the InoDiag method is similar to conventional immunofluorescence. 53 
54 
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INTRODUCTION 55 
Coxiella burnetii, Rickettsia typhi and Rickettsia conorii are the causative agents of Q fever, 56 
murine typhus and Mediterranean spotted fever, respectively [18, 5, 16]. These obligate 57 
intracellular bacteria are difficult to diagnose and culture-based methods are restricted to 58 
specialized BSL3 laboratories. PCR-based detection methods have been described but are 59 
essentially found in larger reference diagnostic laboratories [15, 17]. Therefore, screening 60 
for Q fever and rickettsial diseases often relies on serologic techniques such as Enzyme-61 
linked immunosorbent assays (ELISA), Western-blots (WB) and immunofluorescence assays 62 
(IF). Serology is especially useful for the diagnosis of chronic Q fever, in particular when a 63 
biopsy of the affected organ (e.g. cardiac valve, liver) is not available. Coxiella burnetii 64 
serological diagnosis is based on the presence of antibodies against phase 2 and phase 1 65 
antigens, for the diagnosis of acute and chronic Q fever, respectively. The serological 66 
diagnosis of rickettsial infections is more complex, because of the common occurrence of 67 
cross-reactions between the different spotted fever group rickettsia. Conventional IFs are 68 
labour-intensive and reading of the assay is operator-dependent. Recently, a new innovative 69 
automated epifluorescence assay has been made available by InoDiag (Signes, France) for 70 
the diagnosis of C. burnetii, R. typhi and R. conorii. This multiplexed antigen microarray uses 71 
standardized quantities of antigens, spotted on glass slides with appropriate controls [9]. 72 
Except for the initial deposition of the serum samples, all subsequent steps (i.e. secondary 73 
antibody depositions, incubations, washing, drying, reading and interpretation) are 74 
performed automatically. This assay has previously been shown to be a promising tool for 75 
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the serodiagnosis of Chlamydia trachomatis infection, culture-negative endocarditis and 76 
atypical pneumonia [8, 9, 3]. 77 
In the present study, we compared the performance of the automated InoDiag serological 78 
test with a gold standard indirect micro-immunofluorescence technique on sera taken from 79 
patients with serologically and clinically proven Q fever or rickettsial diseases, as well as on 80 
sera from pregnant women and control patients. 81 
82 
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MATERIALS AND METHODS 83 
Patient population and controls 84 
A total of 213 sera were studied. Tested sera from acute, chronic or past Q fever infections 85 
as well as rickettsiosis cases that were positive for IgM and/or IgG using a reference indirect 86 
micro-immunofluorescence technique (described below) were selected from the routine 87 
serological laboratories of Lausanne and Sion, Switzerland (seroconversion, clinically 88 
confirmed or compatible cases as well as sera from previous studies [2, 6, 13]). This included 89 
20 sera from spotted fever rickettsiosis (11 spotted Mediterranean fever, 9 African tick-bite 90 
fever), 6 sera from murine typhus, 63 sera from Q fever (12 acute, 22 chronic, 29 past 91 
infections). Clinical cases corresponding to some of these sera have been previously 92 
published [1, 4, 10, 11]. A total of 124 control samples were included. These consisted in 10 93 
samples from EBV IgM+ sera, 101 sera from pregnant women and 13 sera from patients with 94 
unrelated infections. 95 
InoDiag 96 
The tested InoDiag assay is a fully automated multiplexed immunofluorescent assay 97 
consisting of glass slides spotted with nanolitre spots of antigens of R. typhi, R. conorii, 98 
R. felis, and C. burnetii antigens (Figure 1). The sensitivity of the assay was not evaluated for 99 
R. felis, the causative agent of cat-flea typhus. Slides also contain four control spots: (i) 100 
S. aureus ATCC 29213 to assess serum deposition, (ii) human IgG to confirm the adequate 101 
distribution of the secondary anti-human IgG antibody, (iii) human IgM to confirm the 102 
adequate distribution of the secondary anti-human IgM antibody and detect the eventual 103 
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presence of rheumatoid factor, (iv) double-stranded DNA to detect antinuclear antibodies. 104 
Serum samples were diluted at a ratio of 1:16 and applied on the slide. All subsequent steps 105 
were performed automatically as previously described [6]. After the final drying step, slides 106 
were imaged with an automatic InoDiag fluorescent camera analyzer and the data processed 107 
using the software Inosoft (InoDiag). The end-point is a fluorescence index. For C. burnetii, 108 
two-cutoffs for positivity were considered: a fluorescence index >1 arbitrary units (AU) and 109 
>2 AU. For Rickettsia, only the cutoff of 2 AU was considered. Receiver operating 110 
characteristics (ROC) curves were used to precise the diagnosis performance of the assay. 111 
Indirect micro-immunofluorescence  112 
Sera were tested for the presence of antibodies directed against C. burnetii or Rickettsia spp. 113 
using indirect micro-immunofluorescence (IF). Briefly, sera were screened at 1:20 to 1:80 114 
dilution in two-fold steps using C. burnetii phase I and II antigens (strain Nine Miles, kindly 115 
provided by Dr W. Burgdorfer, Rocky Mountain Laboratories, Hamilton, USA), R. conorii and 116 
R. typhi (kindly provided by Dr W. Burgdorfer, Rocky Mountain Laboratories, Hamilton, USA) 117 
and R. africae (kindly provided by Dr D. Raoult and Dr. P-E. Fournier). We used fluorescein 118 
isothiocyanate goat anti-human specific IgG and IgM conjugates (BioMérieux, Marcy-l'Etoile, 119 
France). Positive sera were then diluted in two-fold steps from 1:20 to final dilutions. 120 
121 
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RESULTS 122 
Performance of the InoDiag assay in the Q fever group 123 
The assay has been evaluated for the three categories of Q fever disease (acute, chronic and 124 
past infection). The sensitivity and specificity for C. burnetii of the InoDiag assay for the 125 
various tested groups are shown in the Table 1. In the acute Q fever group (n=12), 100% 126 
(12/12) and 83% (10/12) sera were positive by IF for phase 2 IgM and phase 2 IgG, 127 
respectively. The sensitivity of the InoDiag assay for acute Q fever with positive IgG detected 128 
by IF  (irrespective of the presence of IgM) was of 20% (2/10) and 30% (3/10) with cutoffs of 129 
2 and 1 AU, respectively. Considering sera positive in IgM by IF in patients with acute Q 130 
fever, the sensitivity reached 75% (9/12) and 83% (10/12) with cutoffs of 2 AU and 1 AU, 131 
respectively. Two early seroconversions that were detected by IF already on the first sera 132 
(one positive for both IgG and IgM ; one positive for phase 2 IgM only) were missed by the 133 
InoDiag assay.  134 
In the chronic Q fever group, 22 sera were positive for IgG against both phase 1 and phase 2 135 
antigens by IF. Among these, the InoDiag test showed a sensitivity of 100% (22/22) for IgG 136 
detection. Of note, 4 sera exhibited traces of IgM with the IF. With the InoDiag technique, 5 137 
and 3 sera were positive in IgM with cutoff values of 1 AU and 2 AU, respectively. This might 138 
wrongly suggest the false diagnosis of an acute Q fever.  139 
Even though the InoDiag assay is commercialized as a screening tool, we wondered whether 140 
the InoDiag assay could also be used as a tool to monitor treatment efficacy. In successive 141 
sera obtained from three patients treated for chronic Q fever, we did not observe a 142 
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correlation between InoDiag quantitative values and antibody titers measured by IF. Indeed, 143 
over a three year follow-up of a patient with Q-fever endocarditis [11], the initial IgG 144 
antibody reactivity was measured by the InoDiag assay at 5.47 whereas phase 1 and 2 IgG 145 
were quantified at 1:3200 and 1:6400 by IF, respectively. In the subsequent sera, which 146 
corresponds to treatment initiation, InoDiag IgG titres fell from 5.47 to 2.62 whereas IF titres 147 
fell to 1:200 and 1:400. However, for a second patient with proven Q fever [10], InoDiag 148 
values remained constantly highly positive (6.27-5.77) over two years under adequate 149 
treatment demonstrated by decreasing IF titres, that fell from 1:800 to 1:100 and 1:1600 to 150 
1:200 for phase 1 and phase 2 antibodies, respectively. Finally, for a third patient with aortic 151 
prosthesis infection, titers remained elevated by IF a well as by the InoDiag assay. 152 
In the past Q fever group, which included 29 sera tested positive in IgG by IF, 48% (14/29) 153 
and 65% (19/29) were positive in IgG with the InoDiag assay using cutoffs of 2 AU and 1 AU, 154 
respectively. IgG values obtained by the InoDiag assay for past Q fever infections ranged 155 
from 2.07 to >10, which does not differ from the values obtained in the chronic Q fever 156 
group. Thus, the InoDiag test cannot differentiate a past from a chronic Q fever. As well, the 157 
fact that 4 sera were positive only for IgM in the InoDiag assay could lead to the incorrect 158 
diagnosis of an acute recent infection whereas these sera were clearly from past Q fever 159 
with initial diagnosis made 2 to 6 years before. 160 
In the control group, with a cutoff of 1 AU, 6/124 sera (4.8%) were positive for C. burnetii IgG 161 
by the InoDiag assay. Using the higher 2 AU cutoff, only one serum out of 124 (0.8%) was 162 
positive for C. burnetii IgG. This serum originated from an EBV IgM positive patient and was 163 
also tested positive by IF. When considering IF as gold standard (i.e. excluding this sera), the 164 
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specificity of the InoDiag assay would thus be of 100%. No serology was positive among 165 
pregnant women or in patients with unrelated diseases. 166 
Regarding cross-reactions, among the 63 sera from patients with Q fever disease, we 167 
observed a prevalence of 11% (7/63) of Rickettsia antibodies with a cutoff of 2 AU for 168 
Rickettsia. Two and 1 sera were positive for R. typhi IgG and IgM, respectively, 2 sera were 169 
positive for either IgM or IgG against R. conorii, and 2 sera were positive for IgM against both 170 
R. typhi and R. conorii. Only one of these positive reactions in IgM was confirmed by IF. This 171 
apparent cross-positivity might come from the quality of the preparation of the slides, such 172 
as a non pure antigen or contamination during the spotting process. 173 
When the different Q fever status disease (acute, chronic and past infection) are taken into 174 
consideration, the ROC curves show inferior performances to discriminate IgG and IgM anti- 175 
C. burnetii for acute Q fever; with areas under the curve of 0.936 and 0.9426 respectively  176 
(Figure 2). In contrast, areas under the curves are close to 1 for chronic and past infection in 177 
IgG and IgM, which testify an excellent discrimination tool (Figure 2). 178 
 179 
Performance of the InoDiag assay in the Rickettsia spp. group 180 
This group included sera from spotted Mediterranean fever, African tick-bite fever (ATBF) 181 
and murine typhus. The sensitivity and specificity for Rickettsia spp. of the InoDiag assay for 182 
the various tested groups are shown in the Table 2. Among 11 sera taken from patients with 183 
spotted Mediterranean fever confirmed by IF, 91% (10/11) showed antibody reactivity 184 
against R. conorii when tested with the InoDiag assay (Table 2). Eight were positive for both 185 
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IgM and IgG antibodies, and 2 sera were positive for either IgG or IgM antibodies. Of note, 186 
cross reactions (either IgG and/or IgM) with R. typhi and R. felis were common, being 187 
observed for 7/10 and all 10/10 cases, respectively. 188 
Even though no specific Rickettsia africae antigen was spotted on the slide, we tested the 189 
InoDiag assay on 9 sera from ATBF since it is well known that spotted group Rickettsia 190 
exhibit numerous interspecies serological cross-reactions [14, 7]. In our study, 44% (4/9) sera 191 
reacted with the InoDiag assay, 3 being positive for IgG against R. conorii and 1 being 192 
positive for IgG against both R. conorii and R. typhi. 193 
Six sera were obtained from 2 patients with murine typhus. With the conventional IF, 5 sera 194 
were positive for IgM and IgG, 1 sera for IgG only. The InoDiag results were totally 195 
concordant to IF results. Hence, the sensitivity of the InoDiag assay for murine typhus was 196 
100% in our small cases series. Interestingly, in one of these patients coming from a zone of 197 
known endemicity (North Africa), 4 out of 5 sera showed a positive signal for C. burnetii with 198 
the InoDiag method (IgG: 2.21-3.29 ; IgM negative). Since conventional IF for C. burnetii was 199 
negative for all these sera, these results might represent a cross-reaction of the InoDiag 200 
assay rather than serological traces of a past infection. 201 
In the control group, 7 of 124 (5.6%) sera exhibited a positive signal for Rickettsia spp. In the 202 
subgroup of EBV IgM positive patients, 1 sera was positive for IgG towards R. typhi and 1 for 203 
IgG towards R. conorii. None of these were positive with IF. In the subgroup of pregnant 204 
women, 1 sera was positive for IgG towards R. typhi (confirmed by IF), and 2 sera were 205 
positive for IgM towards either R. typhi or R. conorii (negative by IF). In the subset of 206 
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patients with unrelated diseases, the InoDiag assay determined that 1 sera was positive for 207 
IgM against R. typhi and 1 sera was positive for IgM against R. typhi and R. conorii. None of 208 
these sera was confirmed positive by IF. Hence in the control group 5% (6/124) of sera 209 
exhibited a positive signal by InoDiag that was not confirmed by IF. 210 
Regarding cross-reactions with Coxiella, we observed a prevalence of Coxiella antibodies of 211 
40% (8/26) among the 26 sera from patients with rickettsial diseases. Of these 8 sera, only 1 212 
was confirmed by IF. 213 
214 
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DISCUSSION 215 
In this work, we assessed the performance of the InoDiag inoMuST slide for the diagnosis of 216 
Coxiella and Rickettsia infections. 217 
Regarding the diagnosis of Q fever disease, the InoDiag assay has an excellent performance 218 
for the diagnosis of chronic Q fever. However, we observed a very low IgG sensitivity of the 219 
InoDiag assay in acute Q fever, that might be due to an insufficiently reactive phase 2 220 
antigen on the glass slide. In particular, for 10 sera from acute Q fever that were positive in 221 
phase 2 IgG by conventional IF (phase 2 IgG titers ranging from 1:640 to 1: 20’480), only 2 222 
were positive in IgG with the InoDiag assay. This might be due to the fact that the antigen 223 
spotted on the slide is rather a phase 1 antigen than a phase 2 antigen. The defect in phase 2 224 
IgG and IgM detection for the diagnosis of acute Q fever is somehow compensated by the 225 
excellent detection of IgM. However, the InoDiag assay in its present version cannot be 226 
recommended for the diagnosis of acute Q fever. 227 
The InoDiag assay is useful to differentiate a past Q fever from an acute Q fever, but is not 228 
able to distinguish an acute Q fever from a past Q fever with persisting IgM antibodies. As 229 
well, it cannot differentiate a past Q fever from a chronic Q fever. However, because it 230 
exhibits an excellent negative predictive value, the InoDiag assay might be used to rule out a 231 
chronic Q fever, especially in the context of Coxiella intravascular infection or negative blood 232 
culture endocarditis. 233 
Regarding the potential use of the test to monitor treatment efficacy, we did not observe a 234 
correlation between the evolution of serum titers and the signal measured by the InoDiag 235 
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assay. Therefore, it is difficult to base treatment interruption on InoDiag values since it is 236 
currently recommended to treat for at least 18 months, and until a decrease of phase I IgG 237 
titer below 1:400 is observed. 238 
For the diagnosis of Rickettsial diseases, the sensitivity of the InoDiag method is similar to 239 
conventional IF and the InoDiag assay exhibits a good specificity. Of note, the Inodiag slide 240 
provided also includes an antigen spot for Rickettsia felis [12], for which our study design 241 
was not targeted. Nevertheless, R. felis is an emerging pathogen which is likely under 242 
diagnosed and that deserves further studies. It might also be useful to add antigens of 243 
Rickettsia africae, which is typically the most frequently diagnosed rickettsiae in Switzerland 244 
(returning travelers) as well as antigens toward Rickettsia slovaca, an emerging rickettsiosis 245 
in Europe. Interestingly R. felis, which does not belong to either the spotted fever or the 246 
typhus group, exhibits a stronger cross-reactivity with R. typhi than with R. conorii [7]. One 247 
could therefore hypothesize that if serum titers were elevated with both R. typhi and R. felis, 248 
a serological diagnosis of typhus is more likely. In our study, 7 sera from murine typhus were 249 
examined. Of the 6 positive with the InoDiag test, all InoDiag measurements were indeed 250 
higher for R. felis than for R. conorii (data not shown). However, we observed that a higher 251 
R. felis signal was also present in 4/7 sera taken from patients which were in fact presenting 252 
a spotted fever due to R. conorii (all 4 also exhibited some antibody reactivity against R. 253 
typhi). Hence, the purportedly stronger InoDiag cross-reactivity with R. felis of murine typhus 254 
cases cannot reliably be used as a diagnostic indicator. 255 
Because of its ease of use, the InoDiag is a promising technique for the serological diagnosis 256 
of Coxiella and Rickettsia infections. In our opinion, upgrades should nevertheless be made 257 
15 
 
by the manufacturer to improve the diagnosis of acute Q fever and provide a greater range 258 
of antigens representing the diversity of rickettsial species. As well, further prospective 259 
studies should be performed to confirm our data and to assess new versions of the Coxiella 260 
InoDiag assay. 261 
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Figure legends 269 
Figure 1 270 
A) Schematic of the of the glass slide of the multiplexed InoDiag assay. The spots correspond 271 
to the following spotted antigens : IgG, human IgG; CB2, C. burnetii phase 2; RF, R. felis; 272 
dsDNA, double-stranded DNA; SA, S. aureus; IgM, human IgM; RT, R. typhi; RC, R. conorii. 273 
B) Typical slides analysed by a fluorescent camera at different wavelength. UV illumination 274 
(365 nm) allows the determination of the area of each spot and confirms the presence of all 275 
antigens. Fluorescence readings at 470 nm and 594 nm allow the detection and 276 
quantification of IgG and IgM, respectively, towards the various antigens. 277 
 278 
Figure 2 279 
Receiver operating characteristic curves for the performance of the Q fever InoDiag assay on 280 
sera from acute, chronic or past Q fever. 281 
282 
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Table 1 283 
Sensitivity and specificity of the InoDiag assay for C. burnetii 284 
 Setting % ( cutoff 2 AU) 
% 
( cutoff 1 AU) 
Sensitivity    
 Acute Q fever with positive IF IgM 75% 83% 
 Acute Q fever with positive IF phase 2 IgG 
(with or without positive IgM) 
 
 
20% 30% 
 Past Q fever 48% 65% 
 Chronic Q fever with positive IF phase 1 IgG 
(with or without positive IgM) 
100% 100% 
Specificity    
 Healthy patients 100% 100% 
 Patients with other diseases or EBV + sera 100% 82% 
 
 
  
 285 
286 
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Table 2 287 
Sensitivity and specificity of the InoDiag assay for Rickettsia spp. (cutoff of 2 arbitrary 288 
units) 289 
 Setting % 
Sensitivity   
 Spotted Meditteranean fever 91% 
 Murine typhus 100% 
Specificity   
 Healthy patients 98% 
 Patients with other diseases or EBV + sera 79% 
   
 290 
291 
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